Targeting monocytic‐myeloid suppressor cells through CSF1R‐blockade enhances CD19‐CAR T‐cell response in DLBCL
Gödel, P., Stahl, D., Riet, T., Flümann, R., Chmielewski, M., Blakemore, S., Segbers, P., Tetenborg, L., Reinhardt, H. C., Borchmann, P., Ullrich, R.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
Differential ibrutinib sensitivity in Cd79b‐mutant and wildtype subtypes of a novel Myd88‐driven DLBCL mouse model
Flümann, R., Hansen, J., Klein, S., Goldfarb‐Wittkopf, H., Pfeiffer, P., Wirtz, J., Lütz, A. F., Persigehl, T., Büttner, R., Jachimowicz, R., Knittel, G., Reinhardt, H. C.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
AN AUTOCHTHONOUS MOUSE MODEL OF MyD88 p.L265P‐ AND BCL2‐DRIVEN DIFFUSE LARGE B CELL LYMPHOMA
Knittel, G., Flümann, R., Nieper, P., Rehkämper, T., Pfeiffer, P., Holzem, A., Fritz, C., Klatt, A., Kashkar, H., Persigehl, T., Peifer, M., Büttner, R., Reinhardt, C.
Published in Hematological oncology (01.06.2019)
Published in Hematological oncology (01.06.2019)
Get full text
Journal Article